Impact of FGFR3 genomic aberrations in patients with metastatic urothelial carcinoma treated with first line platinum-based chemotherapy
Main Authors: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | European Urology Open Science |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168320336569 |
_version_ | 1818382017705803776 |
---|---|
author | R. Morales Barrera N. Díaz C. Suarez M. Gonzalez E. Serra F. Lozano M. Altabas C. Fernandez M. Hernández S. Gutierrez M. Semidey R. Mast J.M. Rodriguez S. Roche C. Serrano J. Mateo C. Valverde I. De Torres X. Maldonado J. Morote J. Carles |
author_facet | R. Morales Barrera N. Díaz C. Suarez M. Gonzalez E. Serra F. Lozano M. Altabas C. Fernandez M. Hernández S. Gutierrez M. Semidey R. Mast J.M. Rodriguez S. Roche C. Serrano J. Mateo C. Valverde I. De Torres X. Maldonado J. Morote J. Carles |
author_sort | R. Morales Barrera |
collection | DOAJ |
first_indexed | 2024-12-14T02:43:47Z |
format | Article |
id | doaj.art-d06e0c01645f4fdfb0a7688a62d21a90 |
institution | Directory Open Access Journal |
issn | 2666-1683 |
language | English |
last_indexed | 2024-12-14T02:43:47Z |
publishDate | 2020-07-01 |
publisher | Elsevier |
record_format | Article |
series | European Urology Open Science |
spelling | doaj.art-d06e0c01645f4fdfb0a7688a62d21a902022-12-21T23:19:56ZengElsevierEuropean Urology Open Science2666-16832020-07-0119e1585Impact of FGFR3 genomic aberrations in patients with metastatic urothelial carcinoma treated with first line platinum-based chemotherapyR. Morales BarreraN. DíazC. SuarezM. GonzalezE. SerraF. LozanoM. AltabasC. FernandezM. HernándezS. GutierrezM. SemideyR. MastJ.M. RodriguezS. RocheC. SerranoJ. MateoC. ValverdeI. De TorresX. MaldonadoJ. MoroteJ. Carleshttp://www.sciencedirect.com/science/article/pii/S2666168320336569 |
spellingShingle | R. Morales Barrera N. Díaz C. Suarez M. Gonzalez E. Serra F. Lozano M. Altabas C. Fernandez M. Hernández S. Gutierrez M. Semidey R. Mast J.M. Rodriguez S. Roche C. Serrano J. Mateo C. Valverde I. De Torres X. Maldonado J. Morote J. Carles Impact of FGFR3 genomic aberrations in patients with metastatic urothelial carcinoma treated with first line platinum-based chemotherapy European Urology Open Science |
title | Impact of FGFR3 genomic aberrations in patients with metastatic urothelial carcinoma treated with first line platinum-based chemotherapy |
title_full | Impact of FGFR3 genomic aberrations in patients with metastatic urothelial carcinoma treated with first line platinum-based chemotherapy |
title_fullStr | Impact of FGFR3 genomic aberrations in patients with metastatic urothelial carcinoma treated with first line platinum-based chemotherapy |
title_full_unstemmed | Impact of FGFR3 genomic aberrations in patients with metastatic urothelial carcinoma treated with first line platinum-based chemotherapy |
title_short | Impact of FGFR3 genomic aberrations in patients with metastatic urothelial carcinoma treated with first line platinum-based chemotherapy |
title_sort | impact of fgfr3 genomic aberrations in patients with metastatic urothelial carcinoma treated with first line platinum based chemotherapy |
url | http://www.sciencedirect.com/science/article/pii/S2666168320336569 |
work_keys_str_mv | AT rmoralesbarrera impactoffgfr3genomicaberrationsinpatientswithmetastaticurothelialcarcinomatreatedwithfirstlineplatinumbasedchemotherapy AT ndiaz impactoffgfr3genomicaberrationsinpatientswithmetastaticurothelialcarcinomatreatedwithfirstlineplatinumbasedchemotherapy AT csuarez impactoffgfr3genomicaberrationsinpatientswithmetastaticurothelialcarcinomatreatedwithfirstlineplatinumbasedchemotherapy AT mgonzalez impactoffgfr3genomicaberrationsinpatientswithmetastaticurothelialcarcinomatreatedwithfirstlineplatinumbasedchemotherapy AT eserra impactoffgfr3genomicaberrationsinpatientswithmetastaticurothelialcarcinomatreatedwithfirstlineplatinumbasedchemotherapy AT flozano impactoffgfr3genomicaberrationsinpatientswithmetastaticurothelialcarcinomatreatedwithfirstlineplatinumbasedchemotherapy AT maltabas impactoffgfr3genomicaberrationsinpatientswithmetastaticurothelialcarcinomatreatedwithfirstlineplatinumbasedchemotherapy AT cfernandez impactoffgfr3genomicaberrationsinpatientswithmetastaticurothelialcarcinomatreatedwithfirstlineplatinumbasedchemotherapy AT mhernandez impactoffgfr3genomicaberrationsinpatientswithmetastaticurothelialcarcinomatreatedwithfirstlineplatinumbasedchemotherapy AT sgutierrez impactoffgfr3genomicaberrationsinpatientswithmetastaticurothelialcarcinomatreatedwithfirstlineplatinumbasedchemotherapy AT msemidey impactoffgfr3genomicaberrationsinpatientswithmetastaticurothelialcarcinomatreatedwithfirstlineplatinumbasedchemotherapy AT rmast impactoffgfr3genomicaberrationsinpatientswithmetastaticurothelialcarcinomatreatedwithfirstlineplatinumbasedchemotherapy AT jmrodriguez impactoffgfr3genomicaberrationsinpatientswithmetastaticurothelialcarcinomatreatedwithfirstlineplatinumbasedchemotherapy AT sroche impactoffgfr3genomicaberrationsinpatientswithmetastaticurothelialcarcinomatreatedwithfirstlineplatinumbasedchemotherapy AT cserrano impactoffgfr3genomicaberrationsinpatientswithmetastaticurothelialcarcinomatreatedwithfirstlineplatinumbasedchemotherapy AT jmateo impactoffgfr3genomicaberrationsinpatientswithmetastaticurothelialcarcinomatreatedwithfirstlineplatinumbasedchemotherapy AT cvalverde impactoffgfr3genomicaberrationsinpatientswithmetastaticurothelialcarcinomatreatedwithfirstlineplatinumbasedchemotherapy AT idetorres impactoffgfr3genomicaberrationsinpatientswithmetastaticurothelialcarcinomatreatedwithfirstlineplatinumbasedchemotherapy AT xmaldonado impactoffgfr3genomicaberrationsinpatientswithmetastaticurothelialcarcinomatreatedwithfirstlineplatinumbasedchemotherapy AT jmorote impactoffgfr3genomicaberrationsinpatientswithmetastaticurothelialcarcinomatreatedwithfirstlineplatinumbasedchemotherapy AT jcarles impactoffgfr3genomicaberrationsinpatientswithmetastaticurothelialcarcinomatreatedwithfirstlineplatinumbasedchemotherapy |